Key result
CV-A6 strains causing large HFMD epidemics in Osaka City from 2011 to 2015 belonged to distinct genetic clades with unique amino acid substitutions in the VP1 protein compared to earlier strains.
Observational
The emergence of new CV-A6 clades with unique VP1 surface substitutions may explain the large HFMD epidemics in Japan since 2011.
CV-A6 surveillance should continue in Japan; leaves open questions on vaccine development and global spread.
Hand, foot, and mouth disease (HFMD) is an acute febrile illness characterized by fever; sore throat; and vesicular eruptions on the hands, feet, and oral mucosa. Until 2010, HFMD was predominantly associated with enterovirus (EV) A71 and coxsackievirus (CV) A16 in Japan. In 2011, CV-A6 emerged as a primary causative agent, causing the largest HFMD epidemic in Japan since 1981. Since then, CV-A6 has caused large HFMD epidemics every 2 years. The phylogenetic analysis of complete Viral Protein 1 (VP1) sequences revealed that most CV-A6 strains detected from 2011 to 2015 in Osaka City were classified into a different clade compared with CV-A6 strains detected from 1999 until 2009. The majority of CV-A6 strains detected in 2011 and most CV-A6 strains detected from 2013 to 2015 were mainly divided into two distinct genetic groups. Each epidemic strain carried unique amino acid substitutions in the presumed DE, EF, and GH loops of the VP1 protein that is exposed on the surface of the virion. There is a possibility that the appearance of substitutions on the surface of the virion and an accumulation of a susceptible population are significant factors in recent HFMD epidemics.
No takes yet. Share an insight, caveat, or question.
Kanbayashi et al. (2017) conducted an observational in Hand, foot, and mouth disease (HFMD). Coxsackievirus A6 (CV-A6) strains vs. CV-A6 strains detected from 1999 until 2009 was evaluated on Phylogenetic classification and amino acid substitutions in the VP1 protein. CV-A6 strains causing large HFMD epidemics in Osaka City from 2011 to 2015 belonged to distinct genetic clades with unique amino acid substitutions in the VP1 protein compared to earlier strains.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: